The share price at the time of previous FDA decision was about 20c, usually with a 50% discount. The share price has only inches up a couple of pips, despite the instruction for use. Still leaves a ‘bot’ of upside with time to go before the resubmission decision, which doesn’t have an absolute guarantee.
in terms of value if you use Euroz figures as a basis and reverse engineer, it’s sitting at bear case of 0.5% market share with 50% approval discount. A few catalysts to set the scene, approval before-June-after it’s hard to judge exact timing, so expecting FOMO in May.
Sales if approved Q1 and Q2 will be telling of where this is headed. Enjoy!
The share price at the time of previous FDA decision was about...
-
- There are more pages in this discussion • 1,058 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 410003 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 346713 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |